Login / Signup

Emerging technologies and ethics-exogenic chimeric humanized organs.

Mary G GarryArthur L CaplanDaniel J Garry
Published in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2022)
Organ transplantation is limited due to the scarcity of donor organs. In order to expand the supply of organs for transplantation, interspecies chimeras have been examined as a potential future source of humanized organs. Recent studies using gene editing technologies in combination with somatic cell nuclear transfer technology and hiPSCs successfully engineered humanized skeletal muscle in the porcine embryo. As these technologies progress, there are ethical issues that warrant consideration and dialogue.
Keyphrases
  • cell therapy
  • skeletal muscle
  • monoclonal antibody
  • public health
  • single cell
  • insulin resistance
  • stem cells
  • type diabetes
  • current status
  • machine learning
  • bone marrow
  • genome wide
  • deep learning
  • global health